{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:43:45Z","timestamp":1792658625908,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Medicine Supplements"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.amjmed.2005.01.047","type":"journal-article","created":{"date-parts":[[2005,3,29]],"date-time":"2005-03-29T12:31:37Z","timestamp":1112099497000},"page":"23-28","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S2","title":["Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus"],"prefix":"10.1016","volume":"118","author":[{"given":"Steven K.","family":"Grinspoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2005.01.047_bib1","unstructured":"UNAIDS.2004 Report on the Global AIDS Epidemic:4th global report, July 2004. Geneva: Joint United Nations Programme on HIV\/AIDS (UNAIDS). Available at: http:\/\/www.unaids.org\/bangkok2004\/GAR2004_pdf\/UNAIDSGlobalReport2004_en.pdf. Accessed February 22, 2005."},{"key":"10.1016\/j.amjmed.2005.01.047_bib2","unstructured":"UNAIDS\/WHO 2002. AIDS Epidemic Update, December 2002. Geneva: Joint United Nations Programme on HIV\/AIDS (UNAIDS) and World Health Organization (WHO); 2002. Available at: http\/\/www.who.int\/hiv\/facts\/en\/epiupdate_en.pdf. Accessed February 22, 2005."},{"key":"10.1016\/j.amjmed.2005.01.047_bib3","unstructured":"Health Resources and Services Administration HIV\/AIDS Bureau Web site. Available at: http:\/\/www.hab.hrsa.gov\/tools\/primarycareguide\/PCGchap6.htm. Accessed January 12, 2005."},{"key":"10.1016\/j.amjmed.2005.01.047_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(89)90225-8","article-title":"Hypertriglyceridemia in the acquired immunodeficiency syndrome","volume":"86","author":"Grunfeld","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2005.01.047_bib5","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2005.01.047_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00042560-200204150-00003","article-title":"Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy","volume":"29","author":"Koppel","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.amjmed.2005.01.047_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2005.01.047_bib8","series-title":"Ellenberg and Rifkin\u2019s Diabetes Mellitus","first-page":"513","article-title":"Insulin resistance","author":"Olefsky","year":"1997"},{"key":"10.1016\/j.amjmed.2005.01.047_bib9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/368185","article-title":"Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution","volume":"36","author":"Hadigan","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2005.01.047_bib10","series-title":"Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of high Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2001"},{"key":"10.1016\/j.amjmed.2005.01.047_bib11","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2005.01.047_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00042560-200106010-00006","article-title":"Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients","volume":"27","author":"Dube","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.amjmed.2005.01.047_bib13","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1097\/00002030-200409030-00017","article-title":"Indinavir increases glucose production in healthy HIV-negative men","volume":"18","author":"Schwarz","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2005.01.047_bib14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/00002030-200110190-00012","article-title":"Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome","volume":"15","author":"Kosmiski","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2005.01.047_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00042560-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.amjmed.2005.01.047_bib16","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/00002030-200105040-00001","article-title":"Metabolic effects of indinavir in healthy HIV-seronegative men","volume":"15","author":"Noor","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2005.01.047_bib17","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1097\/00002030-199815000-00001","article-title":"Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients","volume":"12","author":"Walli","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2005.01.047_bib18","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy","volume":"13","author":"Saint-Marc","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2005.01.047_bib19","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1097\/00002030-199910220-00035","article-title":"The effects of discontinuing stavudine therapy on clinical and metabolic abnormalities in patients suffering from lipodystrophy","volume":"13","author":"Saint-Marc","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2005.01.047_bib20","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy","volume":"14","author":"Carr","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2005.01.047_bib21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(97)11443-X","article-title":"\u201cBuffalo hump\u201d in men with HIV-1 infection","volume":"351","author":"Lo","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2005.01.047_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1210\/jc.85.1.35","article-title":"Fasting hyperinsulinemia in human immunodeficiency virus-infected men","volume":"85","author":"Hadigan","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2005.01.047_bib23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/ajcn\/76.2.460","article-title":"Body-composition measurements as predictors of glucose and insulin abnormalities in HIV-positive men","volume":"76","author":"Meininger","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.amjmed.2005.01.047_bib24","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/317429","article-title":"Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy","volume":"31","author":"Dube","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2005.01.047_bib25","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2005.01.047_bib26","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1097\/00002030-200011100-00001","article-title":"Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors","volume":"14","author":"Maggi","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2005.01.047_bib27","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/01.CIR.0000124480.32233.8A","article-title":"Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2005.01.047_bib28","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/00002030-200203290-00002","article-title":"Indinavir acutely inhibits insulin-stimulated glucose disposal in humans","volume":"16","author":"Noor","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2005.01.047_bib29","first-page":"22","article-title":"Glucose transport and glucose homeostasis","volume":"10","author":"Mueckler","year":"1995","journal-title":"News Physiol Sci"},{"key":"10.1016\/j.amjmed.2005.01.047_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/338083a0","article-title":"Molecular cloning and characterization of an insulin regulatable glucose transporter","volume":"338","author":"James","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.amjmed.2005.01.047_bib31","doi-asserted-by":"crossref","first-page":"E390","DOI":"10.1152\/ajpendo.1999.276.2.E390","article-title":"GLUT-1 or GLUT-4 transgenes in obese mice improve glucose tolerance but do not prevent insulin resistance","volume":"276","author":"Marshall","year":"1999","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2005.01.047_bib32","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1172\/JCI119711","article-title":"Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene","volume":"100","author":"Rossetti","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjmed.2005.01.047_bib33","first-page":"L4","article-title":"Indinavir acutely inhibits glucose-induced insulin release from pancreatic \u03b2-cells through block of glucose uptake","volume":"7","author":"Koster","year":"2002","journal-title":"Antivir Ther"},{"key":"10.1016\/j.amjmed.2005.01.047_bib34","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00002030-200204120-00005","article-title":"Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations","volume":"16","author":"Murata","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2005.01.047_bib35","first-page":"L36","article-title":"Association of HIV-protease inhibitors with insulin resistance is related to potency of GLUT4 and GLUT1 activity in adipocytes and monocytes","volume":"8","author":"Wang","year":"2003","journal-title":"Antivir Ther"},{"key":"10.1016\/j.amjmed.2005.01.047_bib36","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200411050-00005","article-title":"The effects of HIV protease inhibitors atazanavir and lopinavir\/ritonavir on insulin sensitivity in HIV-seronegative healthy adults","volume":"18","author":"Noor","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2005.01.047_bib37","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.74.5.1045","article-title":"Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome","volume":"74","author":"Grunfeld","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2005.01.047_bib38","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1210\/jc.76.3.559","article-title":"Increased de novo hepatic lipogenesis in human immunodeficiency virus infection","volume":"76","author":"Hellerstein","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2005.01.047_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-200001070-00006","article-title":"Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects","volume":"14","author":"Purnell","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2005.01.047_bib40","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/00002030-200312050-00007","article-title":"Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects","volume":"17","author":"Murphy","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2005.01.047_bib41","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/00126334-200406010-00005","article-title":"Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavir","volume":"36","author":"Wood","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.amjmed.2005.01.047_bib42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00002030-200203080-00008","article-title":"Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers","volume":"16","author":"Fichtenbaum","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2005.01.047_bib43","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.284.4.472","article-title":"Metformin in the treatment of HIV lipodystrophy syndrome","volume":"284","author":"Hadigan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2005.01.047_bib44","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-140-10-200405180-00008","article-title":"Metabolic effects of rosiglitazone in HIV lipodystrophy","volume":"140","author":"Hadigan","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2005.01.047_bib45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00126334-200210010-00006","article-title":"Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone","volume":"31","author":"Gelato","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.amjmed.2005.01.047_bib46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(04)15489-5","article-title":"No effect of rosiglitazone for treatment of HIV-1 lipoatrophy","volume":"363","author":"Carr","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2005.01.047_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/135965350300800303","article-title":"Rosiglitazone in the treatment of HAART-associated lipodystrophy\u2014a randomized double-blind placebo-controlled study","volume":"8","author":"Sutinen","year":"2003","journal-title":"Antivir Ther"}],"container-title":["The American Journal of Medicine Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548276605000130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548276605000130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T11:31:11Z","timestamp":1706095871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548276605000130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":47,"alternative-id":["S1548276605000130"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2005.01.047","relation":{},"ISSN":["1548-2766"],"issn-type":[{"value":"1548-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}